Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.22 | 8e-05 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.19 | 9e-05 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.084 | 0.1 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.081 | 0.1 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.056 | 0.3 |